The landscape of dementia diagnosis has progressed considerably with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology yrs before indicators arise. Though these technological developments depict extraordinary progress in knowing neurodegenerative disorders, th